ID   CERS2_MOUSE             Reviewed;         380 AA.
AC   Q924Z4; Q3TXC5; Q9DCN6;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   07-APR-2021, entry version 163.
DE   RecName: Full=Ceramide synthase 2 {ECO:0000303|PubMed:18165233};
DE            Short=CerS2 {ECO:0000303|PubMed:18165233};
DE            EC=2.3.1.- {ECO:0000269|PubMed:15823095, ECO:0000269|PubMed:18165233, ECO:0000269|PubMed:20110363, ECO:0000269|PubMed:23275342};
DE   AltName: Full=LAG1 longevity assurance homolog 2 {ECO:0000303|PubMed:15823095};
DE   AltName: Full=Sphingosine N-acyltransferase CERS2 {ECO:0000305};
DE            EC=2.3.1.24 {ECO:0000269|PubMed:23275342};
DE   AltName: Full=Translocating chain-associating membrane protein homolog 3 {ECO:0000303|Ref.1};
DE            Short=TRAM homolog 3 {ECO:0000303|Ref.1};
GN   Name=Cers2 {ECO:0000303|PubMed:18165233, ECO:0000312|MGI:MGI:1924143};
GN   Synonyms=Lass2 {ECO:0000303|PubMed:15823095}, Trh3 {ECO:0000303|Ref.1};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Hartmann E.;
RL   Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Liver;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, GLYCOSYLATION AT ASN-19, TISSUE
RP   SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=15823095; DOI=10.1042/bj20050291;
RA   Mizutani Y., Kihara A., Igarashi Y.;
RT   "Mammalian Lass6 and its related family members regulate synthesis of
RT   specific ceramides.";
RL   Biochem. J. 390:263-271(2005).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND TISSUE SPECIFICITY.
RX   PubMed=18165233; DOI=10.1074/jbc.m707386200;
RA   Laviad E.L., Albee L., Pankova-Kholmyansky I., Epstein S., Park H.,
RA   Merrill A.H. Jr., Futerman A.H.;
RT   "Characterization of ceramide synthase 2: tissue distribution, substrate
RT   specificity, and inhibition by sphingosine 1-phosphate.";
RL   J. Biol. Chem. 283:5677-5684(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341; THR-346; SER-348 AND
RP   SER-349, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Kidney, Liver, Lung, Spleen, and
RC   Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND DISRUPTION PHENOTYPE.
RX   PubMed=20110363; DOI=10.1074/jbc.m109.077594;
RA   Pewzner-Jung Y., Park H., Laviad E.L., Silva L.C., Lahiri S., Stiban J.,
RA   Erez-Roman R., Bruegger B., Sachsenheimer T., Wieland F., Prieto M.,
RA   Merrill A.H. Jr., Futerman A.H.;
RT   "A critical role for ceramide synthase 2 in liver homeostasis: I.
RT   alterations in lipid metabolic pathways.";
RL   J. Biol. Chem. 285:10902-10910(2010).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=23275342; DOI=10.1074/jbc.m112.440792;
RA   Yamashita-Sugahara Y., Tokuzawa Y., Nakachi Y., Kanesaki-Yatsuka Y.,
RA   Matsumoto M., Mizuno Y., Okazaki Y.;
RT   "Fam57b (family with sequence similarity 57, member B), a novel peroxisome
RT   proliferator-activated receptor gamma target gene that regulates
RT   adipogenesis through ceramide synthesis.";
RL   J. Biol. Chem. 288:4522-4537(2013).
RN   [9]
RP   ACETYLATION, AND DEACETYLATION BY SIRT3.
RX   PubMed=26620563; DOI=10.1074/jbc.m115.668228;
RA   Novgorodov S.A., Riley C.L., Keffler J.A., Yu J., Kindy M.S., Macklin W.B.,
RA   Lombard D.B., Gudz T.I.;
RT   "SIRT3 deacetylates ceramide synthases: Implications for mitochondrial
RT   dysfunction and brain injury.";
RL   J. Biol. Chem. 291:1957-1973(2016).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH NDUFS2.
RX   PubMed=32279995; DOI=10.1016/j.bbrc.2020.02.166;
RA   Yang Y., Yang X., Lin Y., Yang G., Li L.;
RT   "LASS2 regulates hepatocyte steatosis by interacting with NDUFS2/OXPHOS
RT   related proteins.";
RL   Biochem. Biophys. Res. Commun. 526:871-879(2020).
CC   -!- FUNCTION: Ceramide synthase that catalyzes formation of ceramide from
CC       sphinganine and acyl-CoA substrates, with high selectivity toward very-
CC       long (C22:0-C24:0) chain as acyl donor (PubMed:15823095,
CC       PubMed:18165233, PubMed:23275342). May regulate lipid metabolism in
CC       hepatocytes (PubMed:32279995). {ECO:0000269|PubMed:15823095,
CC       ECO:0000269|PubMed:18165233, ECO:0000269|PubMed:20110363,
CC       ECO:0000269|PubMed:23275342, ECO:0000269|PubMed:32279995}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=docosanoyl-CoA + sphinganine = CoA + H(+) + N-
CC         docosanoylsphinganine; Xref=Rhea:RHEA:36535, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57817, ChEBI:CHEBI:65059,
CC         ChEBI:CHEBI:67021; Evidence={ECO:0000269|PubMed:15823095,
CC         ECO:0000269|PubMed:20110363};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36536;
CC         Evidence={ECO:0000269|PubMed:15823095, ECO:0000269|PubMed:20110363};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=sphinganine + tetracosanoyl-CoA = CoA + H(+) + N-
CC         tetracosanoylsphinganine; Xref=Rhea:RHEA:33591, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:52961, ChEBI:CHEBI:57287, ChEBI:CHEBI:57817,
CC         ChEBI:CHEBI:65052; Evidence={ECO:0000269|PubMed:15823095,
CC         ECO:0000269|PubMed:20110363};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33592;
CC         Evidence={ECO:0000269|PubMed:15823095, ECO:0000269|PubMed:20110363};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexacosanoyl-CoA + sphinganine = CoA + H(+) + N-
CC         hexacosanoylsphinganine; Xref=Rhea:RHEA:33351, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:52962, ChEBI:CHEBI:57287, ChEBI:CHEBI:57817,
CC         ChEBI:CHEBI:64868; Evidence={ECO:0000269|PubMed:15823095,
CC         ECO:0000269|PubMed:18165233, ECO:0000269|PubMed:20110363};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33352;
CC         Evidence={ECO:0000269|PubMed:15823095, ECO:0000269|PubMed:18165233,
CC         ECO:0000269|PubMed:20110363};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(15Z)-tetracosenoyl-CoA + sphinganine = CoA + H(+) + N-(15Z-
CC         tetracosenoyl)-sphinganine; Xref=Rhea:RHEA:36667, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57817, ChEBI:CHEBI:74128,
CC         ChEBI:CHEBI:74130; Evidence={ECO:0000250|UniProtKB:Q96G23};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36668;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxytetracosanoyl-CoA + sphinganine = CoA + H(+) + N-(2-
CC         hydroxytetracosanoyl)-sphinganine; Xref=Rhea:RHEA:36627,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:52371, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57817, ChEBI:CHEBI:74118;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36628;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxydocosanoyl-CoA + sphinganine = CoA + H(+) + N-(2-
CC         hydroxydocosanoyl)-sphinganine; Xref=Rhea:RHEA:36619,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57287, ChEBI:CHEBI:57817,
CC         ChEBI:CHEBI:67023, ChEBI:CHEBI:74117;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36620;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxytetracosenoyl-CoA + sphinganine = CoA + H(+) + N-(2-
CC         hydroxytetracosenoyl)-sphinganine; Xref=Rhea:RHEA:36767,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57287, ChEBI:CHEBI:57817,
CC         ChEBI:CHEBI:74215, ChEBI:CHEBI:74216;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36768;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=sphinganine + tetracosenoyl-CoA = an N-
CC         tetracosenoylsphinganine + CoA + H(+); Xref=Rhea:RHEA:36715,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57287, ChEBI:CHEBI:57817,
CC         ChEBI:CHEBI:74146, ChEBI:CHEBI:74160;
CC         Evidence={ECO:0000269|PubMed:20110363};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36716;
CC         Evidence={ECO:0000269|PubMed:20110363};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=eicosanoyl-CoA + sphinganine = CoA + H(+) + N-
CC         eicosanoylsphinganine; Xref=Rhea:RHEA:36555, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57380, ChEBI:CHEBI:57817,
CC         ChEBI:CHEBI:67027; Evidence={ECO:0000269|PubMed:18165233};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36556;
CC         Evidence={ECO:0000269|PubMed:18165233};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexacosenoyl-CoA + sphinganine = CoA + H(+) + N-
CC         hexacosenoylsphinganine; Xref=Rhea:RHEA:36719, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57817, ChEBI:CHEBI:74161,
CC         ChEBI:CHEBI:74162; Evidence={ECO:0000250|UniProtKB:Q96G23};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36720;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a fatty acyl-CoA + sphing-4-enine = an N-acylsphing-4-enine +
CC         CoA + H(+); Xref=Rhea:RHEA:23768, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:52639, ChEBI:CHEBI:57287, ChEBI:CHEBI:57756,
CC         ChEBI:CHEBI:77636; EC=2.3.1.24;
CC         Evidence={ECO:0000269|PubMed:23275342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23769;
CC         Evidence={ECO:0000269|PubMed:23275342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=sphing-4-enine + tetracosanoyl-CoA = CoA + H(+) + N-
CC         tetracosanoyl-sphing-4-enine; Xref=Rhea:RHEA:37115,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57287, ChEBI:CHEBI:57756,
CC         ChEBI:CHEBI:65052, ChEBI:CHEBI:72965;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37116;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=sphing-4-enine + tetracosenoyl-CoA = CoA + H(+) + N-
CC         (tetracosenoyl)-sphing-4-enine; Xref=Rhea:RHEA:37123,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57287, ChEBI:CHEBI:57756,
CC         ChEBI:CHEBI:74146, ChEBI:CHEBI:74457;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37124;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=heptadecasphing-4-enine + tetracosanoyl-CoA = CoA + H(+) + N-
CC         tetracosanoyl-heptadecasphing-4-enine; Xref=Rhea:RHEA:36739,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57287, ChEBI:CHEBI:65052,
CC         ChEBI:CHEBI:74166, ChEBI:CHEBI:74167;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36740;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoyl-CoA + sphing-4-enine = CoA + H(+) + N-
CC         hexadecanoylsphing-4-enine; Xref=Rhea:RHEA:36687, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, ChEBI:CHEBI:57756,
CC         ChEBI:CHEBI:72959; Evidence={ECO:0000269|PubMed:23275342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36688;
CC         Evidence={ECO:0000269|PubMed:23275342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=octadecanoyl-CoA + sphing-4-enine = CoA + H(+) + N-
CC         octadecanoylsphing-4-enine; Xref=Rhea:RHEA:36691, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57394, ChEBI:CHEBI:57756,
CC         ChEBI:CHEBI:72961; Evidence={ECO:0000269|PubMed:23275342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36692;
CC         Evidence={ECO:0000269|PubMed:23275342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=eicosanoyl-CoA + sphing-4-enine = CoA + H(+) + N-eicosanoyl-
CC         sphing-4-enine; Xref=Rhea:RHEA:45284, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57380, ChEBI:CHEBI:57756,
CC         ChEBI:CHEBI:72962; Evidence={ECO:0000269|PubMed:23275342};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45285;
CC         Evidence={ECO:0000269|PubMed:23275342};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hexadecanoyl-CoA + sphinganine = CoA + H(+) + N-
CC         hexadecanoylsphinganine; Xref=Rhea:RHEA:36539, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, ChEBI:CHEBI:57817,
CC         ChEBI:CHEBI:67042; Evidence={ECO:0000250|UniProtKB:Q96G23};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36540;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(9Z)-octadecenoyl-CoA + sphinganine = CoA + H(+) + N-(9Z-
CC         octadecenoyl)-sphinganine; Xref=Rhea:RHEA:36575, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57387, ChEBI:CHEBI:57817,
CC         ChEBI:CHEBI:74100; Evidence={ECO:0000250|UniProtKB:Q96G23};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36576;
CC         Evidence={ECO:0000250|UniProtKB:Q96G23};
CC   -!- ACTIVITY REGULATION: Ceramide synthase activity is inhibited by
CC       sphingosine-1-phosphate. {ECO:0000250|UniProtKB:Q96G23}.
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC       {ECO:0000269|PubMed:15823095, ECO:0000269|PubMed:18165233,
CC       ECO:0000269|PubMed:20110363, ECO:0000269|PubMed:23275342}.
CC   -!- SUBUNIT: Interacts with ATP6V0C, ASGR1, ASGR2 and SLC22A1/OCT1.
CC       Interacts with ELOV1, HSD17B12 and TECR (By similarity). Interacts with
CC       NDUFS2 (PubMed:32279995). {ECO:0000250|UniProtKB:Q96G23,
CC       ECO:0000269|PubMed:32279995}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:15823095}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Broadly expressed, with highest levels in liver and
CC       kidney. {ECO:0000269|PubMed:15823095, ECO:0000269|PubMed:18165233}.
CC   -!- DOMAIN: The last loop motif confers selectivity toward behenoyl-CoA
CC       (docosanoyl-CoA; C22:0-CoA) and lignoceroyl-CoA (tetracosanoyl-CoA;
CC       C24:0-CoA) as acyl donors. {ECO:0000250|UniProtKB:Q96G23}.
CC   -!- PTM: Acetylated (PubMed:26620563). Deacetylation by SIRT3 increases
CC       enzyme activity and promotes mitochondrial ceramide accumulation
CC       (PubMed:26620563). {ECO:0000269|PubMed:26620563}.
CC   -!- PTM: Phosphorylated at the C-terminus by CK2, leading to increase the
CC       ceramide synthase activity. {ECO:0000250|UniProtKB:Q96G23}.
CC   -!- DISRUPTION PHENOTYPE: Most mice do not survive beyond 16 months
CC       (PubMed:20110363). Ceramide and downstream sphingolipids are devoid of
CC       very long (C22-C24) acyl chains (PubMed:20110363). Total
CC       glycerophospholipid and cholesterol levels are unaltered, while a
CC       marked increase in C18:1 and C18:2 fatty acids in
CC       phosphatidylethanolamine, concomitant with a reduction in C18:0 and
CC       C20:4 fatty acids are observed (PubMed:20110363). Membranes display
CC       higher membrane fluidity and show morphological changes
CC       (PubMed:20110363). {ECO:0000269|PubMed:20110363}.
CC   -!- CAUTION: Contains a predicted homeobox domain which is degenerated and
CC       lacks residues that are important for DNA-binding. The protein
CC       localizes in the endoplasmic reticulum and not in the nucleus, which
CC       also argues against homeobox function (PubMed:15823095).
CC       {ECO:0000269|PubMed:15823095, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY029532; AAK40300.1; -; mRNA.
DR   EMBL; AK050161; BAC34102.1; -; mRNA.
DR   EMBL; AK159325; BAE34991.1; -; mRNA.
DR   EMBL; BC006847; AAH06847.2; -; mRNA.
DR   CCDS; CCDS17612.1; -.
DR   RefSeq; NP_001307421.1; NM_001320492.1.
DR   RefSeq; NP_084065.1; NM_029789.2.
DR   RefSeq; XP_006502323.1; XM_006502260.1.
DR   SMR; Q924Z4; -.
DR   BioGRID; 218381; 48.
DR   IntAct; Q924Z4; 3.
DR   MINT; Q924Z4; -.
DR   STRING; 10090.ENSMUSP00000015858; -.
DR   SwissLipids; SLP:000000116; -.
DR   GlyConnect; 2203; 2 N-Linked glycans (1 site).
DR   GlyGen; Q924Z4; 1 site.
DR   iPTMnet; Q924Z4; -.
DR   PhosphoSitePlus; Q924Z4; -.
DR   SwissPalm; Q924Z4; -.
DR   EPD; Q924Z4; -.
DR   jPOST; Q924Z4; -.
DR   MaxQB; Q924Z4; -.
DR   PaxDb; Q924Z4; -.
DR   PeptideAtlas; Q924Z4; -.
DR   PRIDE; Q924Z4; -.
DR   ProteomicsDB; 281383; -.
DR   Antibodypedia; 20302; 218 antibodies.
DR   Ensembl; ENSMUST00000015858; ENSMUSP00000015858; ENSMUSG00000015714.
DR   GeneID; 76893; -.
DR   KEGG; mmu:76893; -.
DR   UCSC; uc008qjj.1; mouse.
DR   CTD; 29956; -.
DR   MGI; MGI:1924143; Cers2.
DR   eggNOG; KOG1607; Eukaryota.
DR   GeneTree; ENSGT00990000203632; -.
DR   InParanoid; Q924Z4; -.
DR   OMA; IIRMAQK; -.
DR   OrthoDB; 987268at2759; -.
DR   PhylomeDB; Q924Z4; -.
DR   TreeFam; TF314319; -.
DR   BRENDA; 2.3.1.24; 3474.
DR   Reactome; R-MMU-1660661; Sphingolipid de novo biosynthesis.
DR   UniPathway; UPA00222; -.
DR   BioGRID-ORCS; 76893; 12 hits in 45 CRISPR screens.
DR   ChiTaRS; Cers2; mouse.
DR   PRO; PR:Q924Z4; -.
DR   Proteomes; UP000000589; Chromosome 3.
DR   RNAct; Q924Z4; protein.
DR   Bgee; ENSMUSG00000015714; Expressed in liver and 304 other tissues.
DR   Genevisible; Q924Z4; MM.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0016410; F:N-acyltransferase activity; IBA:GO_Central.
DR   GO; GO:0050291; F:sphingosine N-acyltransferase activity; IDA:MGI.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0048681; P:negative regulation of axon regeneration; ISO:MGI.
DR   GO; GO:1900148; P:negative regulation of Schwann cell migration; ISO:MGI.
DR   GO; GO:1905045; P:negative regulation of Schwann cell proliferation involved in axon regeneration; ISO:MGI.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; IMP:UniProtKB.
DR   GO; GO:0030148; P:sphingolipid biosynthetic process; IDA:MGI.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR016439; Lag1/Lac1-like.
DR   InterPro; IPR006634; TLC-dom.
DR   PANTHER; PTHR12560; PTHR12560; 1.
DR   Pfam; PF00046; Homeodomain; 1.
DR   Pfam; PF03798; TRAM_LAG1_CLN8; 1.
DR   PIRSF; PIRSF005225; LAG1_LAC1; 1.
DR   SMART; SM00724; TLC; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS50922; TLC; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Endoplasmic reticulum; Glycoprotein; Lipid biosynthesis;
KW   Lipid metabolism; Membrane; Phosphoprotein; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..380
FT                   /note="Ceramide synthase 2"
FT                   /id="PRO_0000185510"
FT   TOPO_DOM        1..40
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000305|PubMed:15823095"
FT   TRANSMEM        41..61
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        140..160
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        175..195
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        209..229
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        264..284
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        304..324
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        325..380
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q96G23"
FT   DOMAIN          131..332
FT                   /note="TLC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00205"
FT   REGION          67..128
FT                   /note="Homeobox-like"
FT                   /evidence="ECO:0000305"
FT   MOTIF           291..300
FT                   /note="Last loop motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q96G23"
FT   MOD_RES         341
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         346
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         348
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         349
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   CARBOHYD        19
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15823095"
SQ   SEQUENCE   380 AA;  45024 MW;  B6B5EB5397DB19FD CRC64;
     MLQTLYDYFW WERLWLPVNL TWADLEDKDG RVYAKASDLY ITLPLALLFL VIRYFFELYV
     ATPLAALLNV KEKTRLRAPP NATLEHFYQT SGKQPKQVEV DLLSRQSGLS GRQVERWFRR
     RRNQDRPSLL KKFREASWRF TYYLIAFVAG MAVTVDKPWF YDLRKVWEGY PIQSIIPSQY
     WYYMIELSFY WSLLFSIASD VKRKDFKEQI IHHVATIILL CFSWFANYVR AGTLIMALHD
     ASDYLLESAK MFNYAGWKNT CNNLFIVFAI VFIITRLVIM PFWILHCTMI YPLELYPAFF
     GYYFFNFMMA VLQMLHIFWA YFILRMAHKF ITGKLIEDER SDREETESSE GEETAAGAGA
     KSRLLANGHP ILNNNHPKND
//
